X0508 4 2025-12-31 0002012593 Rapport Therapeutics, Inc. RAPP 0002022156 Yeleswaram Krishnaswamy RAPPORT THERAPEUTICS, INC. 99 HIGH STREET, SUITE 2100 BOSTON MA 02110 false true false false Chief Development Officer false Common Stock 2025-12-31 4 A false 9000 A 299831 D Common Stock 2025-12-31 4 S false 2840 30.05 D 296991 D On December 4, 2024, the Reporting Person was granted performance-based restricted stock units ("PSUs") subject to the satisfaction of specified performance criteria as of December 31, 2025. The issuers Compensation Committee confirmed that the performance criteria had been met, resulting in the vesting of such PSUs effective December 31, 2025. Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units, and does not represent a discretionary trade by the reporting person. /s/ Troy Ignelzi, Attorney-in-Fact 2026-01-05